2
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Olsalazine in Patients Intolerant of Sulphasalazine

&
Pages 101-103 | Published online: 08 Jul 2009
 

Abstract

Fifty patients with ulcerative colitis, intolerant of sulphasalazine, were treated with olsalazine, 500 mg twice daily for a 3-month trial period. Thirty-eight of the patients (76%) tolerated the drug well, and all continued to take it beyond the 3-month period. Twelve (24%) were withdrawn because of side-effects, the commonest being diarrhoea. There were no haematological or biochemical abnormalities. Thus, olsalazine is a useful drug for patients who are intolerant of sulphasalazine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.